Kenneth Krogulski - Jun 13, 2024 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Jun 13, 2024
Transactions value $
$3,472
Form type
4
Date filed
7/2/2024, 05:32 PM
Previous filing
Mar 26, 2024
Next filing
Aug 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $204 +134 +0.06% $1.52 241K Jun 13, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $384 +256 +0.11% $1.50 242K Jun 14, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $304 +204 +0.08% $1.49 242K Jun 17, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $320 +204 +0.08% $1.57 242K Jun 18, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $312 +204 +0.08% $1.53 242K Jun 20, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $304 +204 +0.08% $1.49 242K Jun 21, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $347 +218 +0.09% $1.59 243K Jun 24, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $336 +218 +0.09% $1.54 243K Jun 25, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $327 +218 +0.09% $1.50 243K Jun 26, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $331 +218 +0.09% $1.52 243K Jun 27, 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $303 +202 +0.08% $1.50 244K Jun 28, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.